Cervical cancer breakthrough explained as existing drugs cut risk

Using existing drugs to treat cervical cancer before standard treatment could lead to a 35% reduction in the risk of relapse or death, a new study suggests. Researchers from the UCL Cancer Institute and UCLH looked into whether a short course of induction chemotherapy , where a drug is used to destroy as many cancer cells as possible, before chemoradiation , could help with this.

There are around 3,200 new cases every year in the UK, with the five-year survival rate being around 70%, according to Cancer Research UK. CRT has been the standard treatment for cervical cancer patients since 1999, but even though there have been overall significant developments in radiation therapy techniques, up to 30% of people experience their cancer coming back.

What results were found? After five years, researchers discovered that 80% of the people who received a combination of chemotherapy and radiotherapy were alive, whilst 73% had not seen their cancer return or spread. A major benefit, according to researchers, is that it can be incorporated into standard-of-care treatment relatively quickly because cheap, accessible and already-approved ingredients such as carboplatin and paclitaxel are needed for IC.

“This is the biggest improvement in outcome in this disease in over 20 years. I’m incredibly proud of all the patients who participated in the trial; their contribution has allowed us to gather the evidence needed to improve treatment of cervical cancer patients everywhere. We couldn’t have done this without the generous support of Cancer Research UK.”

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Trial results suggest better use of existing drugs increases cervical cancer survival and reduces recurrenceThe INTERLACE phase III trial assessed whether a short course of induction chemotherapy (IC) prior to chemoradiation (CRT) could reduce the rate of relapse and death among patients with locally advanced cervical cancer.
Source: medical_xpress - 🏆 101. / 51 Read more »

Drugs can help to reduce cervical cancer death risk by over a third, study showsResearch has been carried out by University College London's Cancer Institute.
Source: Daily_Record - 🏆 9. / 89 Read more »

Short course of induction chemotherapy can reduce cervical cancer relapse and death by 35%The INTERLACE phase III trial, funded by Cancer Research UK and UCL Cancer Trials Centre, assessed whether a short course of induction chemotherapy (IC) prior to chemoradiation (CRT) could reduce the rate of relapse and death among patients with locally advanced cervical cancer.
Source: NewsMedical - 🏆 19. / 71 Read more »

Cervical cancer treatment switch leads to 'biggest discovery in 20 years'The results could chance cancer treatment forever.
Source: MetroUK - 🏆 13. / 82 Read more »

Cervical cancer treatment switch leads to 'biggest discovery in 20 years'The results could chance cancer treatment forever.
Source: MetroUK - 🏆 13. / 82 Read more »